Relevium Operational Update and Investments for Financial H1 2018

Relevium Technologies (TSXV:RLV) is reporting on an operational update and areas of investment for financial Q2 2018 (October 1, 2017 to December 31, 2017).

As quoted in the press release:

Aurelio Useche, President and CEO of Relevium stated: “The integration, optimization and scale up of BioGanix since acquisition has gone as expected.” Mr. Useche continued: “Operationally we expected a learning curve and expected to overcome all challenges. I think the Operations Team has overcome all challenges and the Company is poised to drive growth in the 2018 calendar year. The e-commerce landscape for nutraceuticals is under constant change and we have been quick on our feet to adapt and maintain sales velocity.”

Click here to read the full press release.